propranolol actavis
teva b.v. - propranololis - plėvele dengtos tabletės - 40 mg - propranolol
urizia
astellas pharma d.o.o. - solifenacino sukcinatas/tamsulozino hidrochloridas - modifikuoto atpalaidavimo tabletės - 6 mg/0,4 mg - tamsulosin and solifenacin
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
ionsys
incline therapeutics europe ltd - fentanilio hidrochloridas - skausmas, po operacijos - analgetikai - ionsys skiriamas ūminio vidutinio sunkumo ir sunkiam pooperaciniam skausmui gydyti suaugusiems pacientams.
epirubicin accord
accord healthcare b.v. - epirubicino hidrochloridas - injekcinis ar infuzinis tirpalas - 2 mg/ml - epirubicin
epirubicin actavis
actavis group ptc ehf. - epirubicino hidrochloridas - injekcinis tirpalas - 2 mg/ml - epirubicin
epirubicin ebewe
sandoz d.d. - epirubicinas - injekcinis ar infuzinis tirpalas - 2 mg/ml - epirubicin
epirubicin kabi
fresenius kabi oncology plc - epirubicinas - injekcinis ar infuzinis tirpalas - 2 mg/ml - epirubicin
varlota
zentiva k.s. - erlotinibas - plėvele dengtos tabletės - 150 mg; 100 mg; 50 mg - erlotinib
tavlesse
instituto grifols s.a. - fostamatinib dinatrio - trombocitopenija - kiti sisteminės hemostatics - tavlesse fluorouracilu ir folino lėtinių imuninė trombocitopenija (ipp) suaugusių pacientų, kuriems yra ugniai atsparios kitiems gydymo.